logo
CAN Community Health and Walgreens Partner for National HIV Testing Day

CAN Community Health and Walgreens Partner for National HIV Testing Day

Business Wire24-06-2025
TAMPA, Fla.--(BUSINESS WIRE)--On National HIV Testing Day, CAN Community Health is partnering with Walgreens to support the national 'Greater Than HIV' campaign. This initiative provides free, confidential HIV testing at Walgreens locations nationwide on Friday, June 27, 2025.
"This partnership with Walgreens reflects our core mission of empowering wellness," said Kal Gajraj, PhD, Chief Marketing Officer at CAN Community Health.
As part of this national initiative, CAN Community Health mobile units will be stationed at select Walgreens locations across the country, offering on-site HIV testing, prevention education, and linkage to care. According to the Centers for Disease Control (CDC), approximately 1.1 million people across the United States are living with HIV today. Nearly 1 in 7 of those individuals are unaware of their status. This effort underscores the shared commitment of CAN Community Health and Walgreens to expand access to healthcare, reduce stigma, and empower individuals to take charge of their health.
"Early detection through routine HIV testing is one of the most effective tools we have to stop the spread of HIV," said Steven Barnett, MD, AAHIVS, Chief Medical Officer at CAN Community Health. "By partnering with Walgreens, we are reaching people where they are, with compassion, dignity, and care."
'Greater Than HIV,' an initiative launched by The Kaiser Family Foundation (KFF), collaborated with 415 organizations and is testing at 575 Walgreens stores nationwide. This year's activation marks a record level of participation in the organization's 15-year history. Since 2011, the partnership between 'Greater Than HIV' and Walgreens has provided more than 93,000 free HIV/STD tests.
"This partnership with Walgreens reflects our core mission of empowering wellness," said Kal Gajraj, PhD, Chief Marketing Officer at CAN Community Health. "By bringing free HIV testing directly into neighborhoods, we're removing barriers and providing the tools people need to stay informed, stay healthy, and live well."
CAN Community Health mobile units will be located at select Walgreens locations in Arlington, Texas; Columbia, South Carolina; Las Vegas, Nevada; Norfolk, Virginia; Phoenix, Arizona, and across Florida in Cape Coral, Daytona Beach, Ft. Lauderdale, Hialeah, Jacksonville, Miami Beach, North Port, Orlando, Sarasota, and Tampa.
About CAN Community Health
CAN Community Health is the nation's premier resource in ending epidemics with a mission of empowering wellness. Headquartered in Tampa, Florida, CAN Community Health operates clinics nationwide across Arizona, Florida, Nevada, South Carolina, Texas, and Virginia. Since 1991, CAN Community Health has delivered high-quality care to those affected by HIV, Hepatitis C, and other sexually transmitted diseases through outreach, integrated clinical practice, advocacy, education, and research. For more information about CAN Community Health and its services, please visit www.CANCommunityHealth.org.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Coloradan participating in this weekend's Donor Dash in Denver says transplantation changed his life: 'It saved me'
Coloradan participating in this weekend's Donor Dash in Denver says transplantation changed his life: 'It saved me'

CBS News

time34 minutes ago

  • CBS News

Coloradan participating in this weekend's Donor Dash in Denver says transplantation changed his life: 'It saved me'

The 26th annual Donor Dash takes place this weekend in Denver, and among the participants will be a Coloradan whose life was changed drastically by transplantation. A dozen years ago Doug French, 74, was struggling with burning eyes and swelling. He was living with hepatitis C. "It didn't stop me, but it surely slowed me down," he said. While he was holding out hope the newer treatments would assist with his situation, French went to meet with the hepatologist. "He said, 'If you don't get a transplant, you won't survive.' And I went, 'Oh, I see. I got this.' That changed everything." French was living in Colorado at the time and was put on a transplant list in Oregon. So he and his wife moved temporarily to Portland and lived in a hotel for four months before he got the call they were hoping for. A recently deceased organ donor had a liver that was a match. "Waking up from that transplant was a miracle. For the first time in years, my eyes weren't burning from hepatitis C," French said. French recently celebrated 10 years since receiving his new organ, and with his body functioning at a higher level, he has lost 110 pounds. He has always been an avid scuba diver, and in addition to making it easier for him to do one of his favorite hobbies, his new liver has allowed him to take other activity levels to new lengths. He completed his first half marathon in April. That was something he wasn't even thinking about prior to his transplant. "Was it even on the back of your mind: 'One day I'm going to do a half marathon?'" CBS Colorado's Michael Spencer asked French. "Oh no, no, no," said French, who jogged with his nephew-in-law. "During that particular time, I kind of like draw a blank about my life and about my future. I had no idea what was next. It saved me. And I've I can't say enough about how grateful I am," he said. The Donor Dash takes place on Sunday at Washington Park. CBS Colorado is a sponsor of the event and Spencer serve as the emcee of the event. Find out how you can register for the event or help the Donor Alliance at

Stefani Du Toit is fighting HIV/Aids stigma
Stefani Du Toit is fighting HIV/Aids stigma

News24

timean hour ago

  • News24

Stefani Du Toit is fighting HIV/Aids stigma

Stefani du Toit is a doer. The 33-year-old has dedicated her adult years to working in the public healthcare sector. 'My work strongly stems from trying to make a positive impact [on] those in a more vulnerable situation,' she told News24. Du Toit is a researcher at the Institute for Life Course Health Research and holds a PhD from Stellenbosch University. Her primary research focuses on substance use and chronic conditions, with a specific focus on HIV and treatment adherence. The 33-year-old's work specialises in adolescent mental health with research spanning seven African countries. She has contributed to developing World Health Organisation guidelines on mental health promotion and preventive interventions for adolescents. Most recently, she received funding from the Faculty of Medicine and Health Sciences' Early Career Research Fund for work on refugee populations.

Veracyte to Release Second Quarter 2025 Financial Results on August 6, 2025
Veracyte to Release Second Quarter 2025 Financial Results on August 6, 2025

Business Wire

time6 hours ago

  • Business Wire

Veracyte to Release Second Quarter 2025 Financial Results on August 6, 2025

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the second quarter of 2025 after the close of market on Wednesday, August 6, 2025. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day. The conference call will be webcast live from the company's website and will be available via the following link: A webcast replay will be available following the conclusion of the live broadcast and will be accessible on the company's website at The conference call dial-ins can be accessed by registering via this link. About Veracyte Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our Veracyte Diagnostics Platform delivers high-performing cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine, which ultimately drives durable reimbursement and guideline inclusion for our tests, along with new insights to support continued innovation and pipeline development. For more information, please visit or follow us on LinkedIn or X (Twitter).

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store